|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,445.00 JPY | +3.23% |
|
+1.60% | -9.72% |
| 07-21 | Japan Shares Rebound as Tech Earnings Season Commences | MT |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| Market Cap | 11,869B 72.43B 63.7B 59.18B 54.43B 102B 7,014B 104B 708B 276B 3,421B 272B 266B | P/E 2026 * |
23.3x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 10,947B 66.8B 58.75B 54.58B 50.2B 94.14B 6,469B 95.83B 653B 255B 3,155B 251B 245B | EV / Sales 2026 * |
7.89x | EV / Sales 2027 * | 6.97x |
| Free-Float |
38.12% | Yield 2026 * |
1.89% | Yield 2027 * | 2.18% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +2.43% | ||
| 1 week | +0.85% | ||
| Current month | -1.95% | ||
| 1 month | -1.51% | ||
| 3 months | -16.48% | ||
| 6 months | -15.02% | ||
| Current year | -10.38% |
| 1 week | 7,163 |  | 7,444 |
| 1 month | 7,105 | | 7,939 |
| Current year | 7,105 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,939 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | +0.85% | +2.06% | +81.54% | 73.72B | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.48% | +18.87% | +17.81% | 264B | |
| +0.25% | -4.62% | -27.66% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.63% | +0.52% | +23.61% | +53.25% | 363.12B | |
| Weighted average by Cap. | +1.75% | +1.15% | +34.73% | +75.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.47B 7.45B 6.92B 6.36B 11.93B 820B 12.15B 82.72B 32.27B 400B 31.79B 31.1B | 1,535B 9.37B 8.24B 7.65B 7.04B 13.2B 907B 13.44B 91.53B 35.7B 443B 35.17B 34.41B |
| Net income | 509B 3.11B 2.73B 2.54B 2.33B 4.38B 301B 4.46B 30.34B 11.84B 147B 11.66B 11.41B | 593B 3.62B 3.18B 2.96B 2.72B 5.1B 350B 5.19B 35.34B 13.79B 171B 13.58B 13.29B |
| Net Debt | -922B -5.63B -4.95B -4.6B -4.23B -7.93B -545B -8.07B -54.97B -21.44B -266B -21.12B -20.66B | -1,164B -7.1B -6.25B -5.8B -5.34B -10.01B -688B -10.19B -69.4B -27.07B -336B -26.67B -26.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ¥7,445.00 | +3.23% | 1,135,900 |
| 23/07/26 | ¥7,212.00 | -1.29% | 2,609,800 |
| 22/07/26 | ¥7,306.00 | -1.23% | 2,064,700 |
| 21/07/26 | ¥7,397.00 | +0.98% | 3,264,000 |
| 17/07/26 | ¥7,325.00 | +1.16% | 2,964,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
